B
Basel Medical Group Ltd
NASDAQ:BMGL
Basel Medical Group Ltd
NASDAQ:BMGL
Price:
4.45
USD
0.45%
Market Closed
Market Cap:
$7m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
B
|
Basel Medical Group Ltd
NASDAQ:BMGL
|
SG |
|
Sands China Ltd
OTC:SCHYY
|
MO |
|
Microsoft Corp
NASDAQ:MSFT
|
US |
|
Develop Global Ltd
OTC:VTEXF
|
AU |
|
Vita Coco Company Inc
NASDAQ:COCO
|
US |
|
Kencana Agri Ltd
SGX:BNE
|
SG |
|
InnovAge Holding Corp
NASDAQ:INNV
|
US |
|
V
|
Victoria PLC
OTC:VCCTF
|
UK |
Intrinsic Value
Not Available for BMGL
There is not enough data to reliably calculate the intrinsic value for Basel Medical Group Ltd.
Do our valuations actually work? See backtest results .
Alternatives to BMGL
Fundamental Analysis
What Basel Medical Group Does
Basel Medical Group Ltd is a Singapore-based healthcare provider focused on specialist medical care, especially orthopaedics, trauma, and related surgical and rehabilitation services. It treats patients with bone, joint, muscle, and sports injuries through consultations, diagnostics, procedures, and follow-up care.
- Headquarters
- Singapore SG
- IPO date
- Feb 25, 2025
Efficiency
Earnings Waterfall
Basel Medical Group Ltd
Basel Medical Group Ltd
